BRIEF published on 07/08/2024 at 16:20, 2 months 26 days ago APEIRON Biologics to be Acquired by Ligand Pharmaceuticals for USD 100 Million Acquisition Investment Biotech Immuno-oncology QARZIBA®
PRESS RELEASE published on 07/08/2024 at 16:15, 2 months 26 days ago APEIRON Biologics to be Acquired by Ligand Pharmaceuticals for USD 100 Million APEIRON Biologics AG to be Acquired by Ligand Pharmaceuticals for USD 100 Million. Ligand will also invest up to USD 4 million in APEIRON spin-off, invIOs Acquisition Immuno-oncology Biotech Company APEIRON Biologics AG Ligand Pharmaceuticals
Published on 10/03/2024 at 23:00, 31 minutes ago CMG Home Loans Announces the Opening of New Tampa Branch
Published on 10/03/2024 at 22:45, 46 minutes ago Rektron Schedules Annual General and Special Meeting of Shareholders in Response to Shareholder Requisition
Published on 10/03/2024 at 22:30, 1 hour 1 minute ago Line5 Earns Top Honors for Fourth Consecutive Year at the 2024 Dealers' Choice Awards
Published on 10/03/2024 at 22:17, 1 hour 14 minutes ago abrdn Asia-Pacific Income Fund, Inc. (FAX) Announces Issuance Of Series B Mandatory Redeemable Preferred Shares
Published on 10/03/2024 at 22:01, 1 hour 29 minutes ago Redcare Pharmacy achieves 81% growth in Q3 Rx sales in Germany, 108% in September and decides to accelerate marketing based on very convincing e-Rx metrics.
Published on 10/03/2024 at 22:01, 1 hour 30 minutes ago Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn’s Disease
Published on 10/03/2024 at 21:57, 1 hour 33 minutes ago EQS-Adhoc: Redcare Pharmacy achieves 81% growth in Q3 Rx sales in Germany, 108% in September and decides to accelerate marketing in Q4 based on very convincing e-Rx metrics. Full-year guidance updated.
Published on 10/03/2024 at 18:45, 4 hours 45 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 10/03/2024 at 17:45, 5 hours 46 minutes ago Aéroports de Paris SA - Voting rights as of 30 September 2024
Published on 10/03/2024 at 17:45, 5 hours 46 minutes ago CHARGEURS - Voting rights monthly statement as of September 30th, 2024
Published on 10/03/2024 at 17:42, 5 hours 48 minutes ago Mersen: Number of shares and voting rights as of September 30, 2024
Published on 10/03/2024 at 08:00, 15 hours 30 minutes ago KURMA PARTNERS ACHIEVES FIRST CLOSE OF NEW EUR 250 MILLION BIOFUND IV
Published on 10/02/2024 at 18:50, 1 day 4 hours ago AXA: Elimination of the dilutive impact of Shareplan 2024